Icpa Health Products Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.45 M
- Company Age 41 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.12 Cr
- Revenue Growth 7.41%
- Profit Growth -24.35%
- Ebitda -8.21%
- Net Worth 12.87%
- Total Assets 12.35%
About Icpa Health Products
Icpa Health Products Ltd (IHPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 20 August 1983 and has a history of 41 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.45 M.
The company has closed loans amounting to ₹3.12 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hiral Chheda, Vishal Shah, Nehal Shah, and Two other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24200MH1983PLC030670
- Company No.
030670
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Aug 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Icpa Health Products Ltd offer?
Icpa Health Products Ltd offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Toothbrush, Dentist Tools, Equipment & Supplies, Dentures, Common Disease Medicines, Oral Care Products, Oral Care Kit, Cosmetics, Hair & Beauty Products, Body Cream, Bath Soaps.
Who are the key members and board of directors at Icpa Health Products?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rohit Mehta ![]() | Managing Director | 20-Aug-1983 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishal Shah ![]() | Director | Current | |
Hiral Chheda ![]() | Whole-Time Director | 01-Apr-2000 | Current |
Nehal Shah ![]() | Director | Current | |
Abha Damani ![]() | Whole-Time Director | 01-Apr-2000 | Current |
Financial Performance of Icpa Health Products.
Icpa Health Products Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 7.41% increase. The company also saw a substantial fall in profitability, with a 24.35% decrease in profit. The company's net worth Soared by an impressive increase of 12.87%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Icpa Health Products?
In 2023, Icpa Health Products had a promoter holding of 89.75% and a public holding of 10.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹31.20 M
Charges Breakdown by Lending Institutions
- Bank Of India : 2.15 Cr
- Gujarat State Financial Corp. : 0.97 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
11 Jan 1999 | Bank Of India | ₹1.85 Cr | Satisfied |
23 Apr 1992 | Gujarat State Financial Corp. | ₹5.70 M | Satisfied |
20 Dec 1985 | Bank Of India | ₹1.20 M | Satisfied |
22 Jul 1985 | Gujarat State Financial Corp. | ₹2.00 M | Satisfied |
22 Jul 1985 | Gujarat State Financial Corp. | ₹2.00 M | Satisfied |
How Many Employees Work at Icpa Health Products?
Icpa Health Products has a workforce of 653 employees as of Sep 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Icpa Health Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icpa Health Products's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.